Operating income fell for all but two insurance divisions operated by major payers in the fourth quarter. And 2025 may be no ...
The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission ...
One pharmacist drew attention to a massive pricing disparity on a key cancer drug, and that disparity may help to explain why ...
Pharmacy Benefit Managers (PBMs) have evolved from relatively obscure cost-saving entities into powerful industry players ...
The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri ...
Hunter Smith offers a restaurant analogy in trying to illustrate the severe financial squeeze that pharmacy benefit managers ...
Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.
After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...
The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher ...
Our health care system is in critical condition, and it’s core sickness is monopolies,” she said in a virtual event ...
According to the author of the study: "If the U.S. were to sustain a national hospital occupancy of 85 percent or greater, it is likely that we would see tens to hundreds of thousands of excess ...
A Missouri district court judge on Tuesday said stopping the FTC’s suit against the Big Three PBMs would be “against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback